Fluorine-19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26511652)

Published in Stem Cells Transl Med on October 28, 2015

Authors

Laura C Rose1, Deepak K Kadayakkara2, Guan Wang3, Amnon Bar-Shir1, Brooke M Helfer4, Charles F O'Hanlon4, Dara L Kraitchman5, Ricardo L Rodriguez6, Jeff W M Bulte7

Author Affiliations

1: Division of Magnetic Resonance Research, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
2: Division of Magnetic Resonance Research, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
3: Department of Electrical and Computer Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
4: Celsense Inc., Pittsburgh, Pennsylvania, USA.
5: Division of Magnetic Resonance Research, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
6: CosmeticSurg, LLC, Luthersville, Maryland, USA.
7: Division of Magnetic Resonance Research, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Chemical & Biomolecular Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA jwmbulte@mri.jhu.edu.

Associated clinical trials:

19F Hot Spot MRI of Human Adipose-derived Stem Cells for Breast Reconstruction (CS-1000) | NCT02035085

Articles cited by this

Cadherin cell adhesion receptors as a morphogenetic regulator. Science (1991) 13.78

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80

In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol (2005) 5.49

Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg (2007) 4.00

Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy (2013) 3.46

Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med (2005) 3.28

Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg (2007) 3.25

In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol (2009) 2.85

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol (2010) 2.57

Stromal vascular progenitors in adult human adipose tissue. Cytometry A (2010) 2.53

Adipose stromal vascular fraction isolation: a head-to-head comparison of four commercial cell separation systems. Plast Reconstr Surg (2013) 2.33

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res (2003) 2.32

Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet (2013) 2.26

Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg Oncol (2012) 2.08

Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells. Dermatol Surg (2008) 2.02

The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy (2013) 1.99

Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation (2008) 1.94

Determining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstruction. Aesthetic Plast Surg (2010) 1.79

Hot spot MRI emerges from the background. Nat Biotechnol (2005) 1.78

Iron administration before stem cell harvest enables MR imaging tracking after transplantation. Radiology (2013) 1.70

In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med (2008) 1.56

Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant (2011) 1.54

Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol (2007) 1.49

Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. Breast J (2009) 1.46

Concise review: adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical implications for tissue engineering therapies in regenerative surgery. Stem Cells Transl Med (2012) 1.25

Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc Imaging (2010) 1.22

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med (2013) 1.21

Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med (2014) 1.15

Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol Imaging (2011) 1.15

The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells. J Tissue Eng Regen Med (2009) 1.14

Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use. Stem Cells Transl Med (2013) 1.07

A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet-rich plasma improves fat grafting maintenance in breast reconstruction. Stem Cells Transl Med (2012) 1.07

Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI. Nanomedicine (Lond) (2013) 1.01

Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up. Cell Transplant (2012) 1.00

Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging. Circ Cardiovasc Imaging (2012) 0.98

Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis. Stem Cell Res Ther (2014) 0.98

Pooled human platelet lysate versus fetal bovine serum-investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use. Cytotherapy (2013) 0.92

Tracking the fate of stem cell implants with fluorine-19 MRI. PLoS One (2015) 0.90

In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence. Int J Nanomedicine (2014) 0.89

Cellular magnetic resonance with iron oxide nanoparticles: long-term persistence of SPIO signal in the CNS after transplanted cell death. Nanomedicine (Lond) (2014) 0.86

Age influence on stromal vascular fraction cell yield obtained from human lipoaspirates. Cytotherapy (2014) 0.85

Science to practice: can stem cells be labeled inside the body instead of outside? Radiology (2013) 0.84

¹⁹F MRI tracer preserves in vitro and in vivo properties of hematopoietic stem cells. Cell Transplant (2012) 0.84

Proliferative and phenotypical characteristics of human adipose tissue-derived stem cells: comparison of Ficoll gradient centrifugation and red blood cell lysis buffer treatment purification methods. Cytotherapy (2014) 0.81

Autologous hematopoietic cell transplantation: an update for clinicians. Ann Med (2014) 0.80

Heterogeneity in the effect of albumin and other resuscitation fluids on intracellular oxygen free radical production. J Trauma (2004) 0.79

In vitro assessment of cytotoxicity and labeling efficiency of 99mTc-HMPAO with stromal vascular fraction of adipose tissue. Nucl Med Biol (2014) 0.77

Histidine inhibits the degradation of cells suspended in Ringer's lactate. J Trauma (2007) 0.77